The main contraindication is pregnancy and breastfeeding, where no safety data exists for any research peptide
Why This Piece BPC157 is heavily marketed online as a healing, gut, tendon, anti inflammatory and longevity peptide despite a very small public human evidence base and no large blinded randomized controlled trials (RCTs) establishing efficacy or long term safety
Starting cagrilintide when already on retatrutide If you are already established on retatrutide at a stable dose (meaning you have been at your current retatrutide dose for at least four weeks without significant GI issues), you can introduce cagrilintide at its lowest starting dose of 0.25 mg weekly
Note any concerning symptoms to discuss at follow-up appointments
Lower risk of anemia Vitamin B12 is required to produce healthy red blood cells
Key Takeaways The standard initial dose for severe deficiency is 1,000 mcg intramuscularly daily or every other day